RPRX

Insider trade Sale by Coyne Terrance P. (EVP & CFO)

4d ago

Insider trade Sale by Urist Marshall (EVP, Research & Investments)

11d ago

Short volume Short volume 57% of volume (3.5σ)

13d ago

News Biogen Q4 Earnings: Revenue And EPS Beat, Warns Lower 2025 Revenue, Inks R&D Funding Pact With Royalty Pharma

14d ago

News Agios (AGIO) Up 21% on Upbeat Data From 2nd Thalassemia Study

14d ago

News Agios (AGIO) Up 23% on Selling Brain Cancer Drug Royalty

14d ago

News Why Cytokinetics (CYTK) Stock Price Was Down 17% on Thursday

14d ago

News Heart Disease-Focused Cytokinetics Operations Are On Track Despite Acquisition Uncertainty, Analysts Observe

14d ago

Insider trade Sale by Urist Marshall (EVP, Research & Investments)

17d ago

Insider trade Sale by Norden Gregory

17d ago

Insider trade Sale by Terrance P. Coyne (EVP & CFO)

32d ago

SEC filing RPRX Announces $2B Daraxonrasib Royalty Deal, $750M FDA Approval Milestone, 4.55% Tiered Royalties

50d ago

Insider trade Sale by Terrance P. Coyne (EVP & CFO)

68d ago

News Denali gains on FDA approval of lead asset

69d ago

Insider trade Sale by Terrance P. Coyne (EVP & CFO)

89d ago

Insider trade Sale by Terrance P. Coyne (EVP & CFO)

104d ago

Insider trade Sale by Marshall Urist

104d ago

Insider trade Sale by Terrance P. Coyne

104d ago

Insider trade Sale by Marshall Urist (EVP, Research & Investments)

104d ago

Insider trade Sale by Marshall Urist

104d ago

News Custodian Property Income REIT plc: Strategic Acquisition of £36m Family Property Portfolio – Company Announcement

106d ago

News Royalty Pharma Q4 Earnings Call Highlights

111d ago

News Royalty Pharma promises $500M to Teva for advancing vitiligo treatment

141d ago

News Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

141d ago

News Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

141d ago